BeStock  
Stocks › Biotechnology › ASND

Ascendis Pharma A/S ASND

US equityMarket cap rank #681Biotechnology
$227.46 −$0.37 (-0.16%)
Market open · Oct 1, 1:20 pm ET · After hours $227.83 0.00%
Open$228.03
Prev close$227.83
Day range$226.76 – $229.66
Volume408.7K
Market cap$14.97B
P/E (TTM)17.9
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership103.6%+0.13 pts vs. prior quarter
Institutions holding371+5 vs. prior quarter

The five largest holders on file together own 48.3% of shares outstanding.

Largest holders

  • RA Capital Management, L.P.15.66%
  • T. Rowe Price Group, Inc.11.99%
  • Avoro Capital Advisors LLC7.78%
  • Westfield Capital Management Company, L.P.7.31%
  • Janus Henderson Group plc5.56%
  • FMR5.40%
  • Capital Research4.49%
  • Artisan Partners Limited Partnership4.01%

By investor type

  • Mutual Fund68.04%
  • VC/PE Fund18.25%
  • Hedge Fund13.02%
  • Public Company2.22%
  • Private Company0.94%
  • Government Pension Fund0.58%
  • Sovereign Wealth Fund0.33%
  • Insurance Company0.09%

No ownership data on file for this stock.

Discussion

No comments yet — be the first to weigh in on ASND.

Leave a comment

Scroll to Top